文献
J-GLOBAL ID:201202252710794754
整理番号:12A0596351
転移性去勢抵抗性前立腺癌の化学療法未実施患者でのドセタキセルとプレドニゾン併用スニチニブ 第I/II相臨床試験
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial
著者 (13件):
ZURITA A.J.
(Univ. Texas MD Anderson Cancer Center, Houston)
,
GEORGE D.J.
(Duke Univ. Medical Center, Durham)
,
SHORE N.D.
(Carolina Urologic Res. Center, Myrtle Beach)
,
LIU G.
(Univ. Wisconsin Carbone Cancer Center, Madison)
,
WILDING G.
(Univ. Wisconsin Carbone Cancer Center, Madison)
,
HUTSON T.E.
(Baylor Sammons Cancer Center-Texas Oncology, Dallas)
,
KOZLOFF M.
(Ingalls Memorial Hospital, Harvey)
,
MATHEW P.
(Univ. Texas MD Anderson Cancer Center, Houston)
,
HARMON C.S.
(Pfizer Oncology, La Jolla, USA)
,
WANG S.L.
(Pfizer Oncology, La Jolla, USA)
,
CHEN I.
(Pfizer Oncology, La Jolla, USA)
,
MANEVAL E.Chow
(Pfizer Oncology, La Jolla, USA)
,
LOGOTHETIS C.J.
(Univ. Texas MD Anderson Cancer Center, Houston)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
23
号:
3
ページ:
688-694
発行年:
2012年03月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)